Details:

Alternative Title:
MMWR Morb Mortal Wkly Rep
Publisher's site:
http://dx.doi.org/10.15585/mmwr.mm6716a4
Personal Author:
Weston, Emily J. ; Workowski, Kimberly ; Torrone, Elizabeth ; Weinstock, Hillard ; Stenger, Mark R.
Weston, Emily J. ; Workowski, Kimberly ; Torrone, Elizabeth ; Weinstock, Hillard ; Stenger, Mark R. Less -
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
Description:
Gonorrhea, the sexually transmitted disease (STD) caused by Neisseria gonorrhoeae, is the second most common notifiable disease in the United States after chlamydia; 468,514 cases were reported to state and local health departments in 2016, an increase of 18.5% from 2015 (1). N. gonorrhoeae has progressively developed resistance to most antimicrobials used to treat the infection (2). As a result, CDC recommends two antimicrobials (250 mg of ceftriaxone [IM] plus 1 g of azithromycin [PO]) for treating uncomplicated gonorrhea to improve treatment efficacy and, potentially, to slow the emergence and spread of antimicrobial resistance. To monitor adherence to the current CDC-recommended regimen for uncomplicated gonorrhea, CDC reviewed enhanced data collected on a random sample of reported cases of gonorrhea in seven jurisdictions participating in the STD Surveillance Network (SSuN) and estimated the proportion of patients who received the CDC-recommended regimen for uncomplicated gonorrhea, by patient characteristics and diagnosing facility type. In 2016, the majority of reported patients with gonorrhea (81%) received the recommended regimen. There were no differences in the proportion of patients receiving the recommended regimen by age or race/ethnicity; however, patients diagnosed with gonorrhea in STD (91%) or family planning/reproductive health (94%) clinics were more likely to receive this regimen than were patients diagnosed in other provider settings (80%). These data document high provider adherence to CDC gonorrhea treatment recommendations in specialty STD clinics, indicating high quality of care provided in those settings. Local and state health departments should monitor adherence with recommendations in their jurisdictions and consider implementing interventions to improve provider and patient compliance with gonorrhea treatment recommendations where indicated.
Subject:
[+]
Adolescent
Adult
Anti-Bacterial Agents
Azithromycin
Ceftriaxone
Drug Therapy, Combination
Female
Full Report
Gonorrhea
Guideline Adherence
Humans
Male
Middle Aged
Population Surveillance
Practice Guidelines As Topic
Young Adult

Source:
MMWR Morb Mortal Wkly Rep. 67(16):473-476.
Pubmed ID:
29698384
Pubmed Central ID:
PMC5919606
Document Type:
Journal Article
Place as Subject:
United States
Collection(s):
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:33b4be0979548b93f5bcecdbacf853f0b47244fac94b6886f98c56f2021f74cd
File Type:

Supporting Files

• mm6716a4.nxml

  xml

More +